NEAUTUS(02206.HK) closed 71.64% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
NewTimeSpace News: On 11 November 2026, its first trading day on the Main Board of the Stock Exchange, Sichuan Neautus Traditional Chinese Medicine Co., Ltd. (02206.HK) closed at HK$69.00, up HK$28.80 or 71.64% from the final offer price of HK$40.20. The shares traded between an intraday high of HK$88.10 and a low of HK$51.25, with turnover of HK$194 million for the day, bringing the latest market capitalisation to HK$4,497 million.
On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which NEAUTUS belongs, showed an overall divergence trend, with 44 stocks advancing and 96 stocks declining.Among the gainers, NEAUTUS closed higher by 71.64%, JIANGXI BIO closed higher by 10.18%, JOYZYME GROUP closed higher by 7.55%, VIGONVITA-B closed higher by 6.69%, ABBISKO-B closed higher by 5.22%.Among the decliners, NEW RAY MEDIC closed lower by 8.22%, CUTIA-B closed lower by 7.79%, MICOT PHARMA-B closed lower by 7.79%, IMPACT THERAP-B closed lower by 7.35%, PEGBIO CO-B closed lower by 6.86%.
- Hong Kong Recently Listed Stocks Daily Report: AMICRO Rises 38.18% to Lead, Technology and Pharmaceutical Sectors Heat Up-20261112
- Hong Kong Recently Listed Stocks Daily Report: NEAUTUS Surges 71.64% to Lead the Traditional Chinese Medicine Sector, Telecom Equipment and Semiconductor Chain Strengthen-20261111
- NEAUTUS (02206.HK): debuts 84.08% higher at HK$74.00
- NEAUTUS (02206.HK): grey market price at HK$49.50, up 23.13% from HK$40.20 offer price, listing on 11 November
- NEAUTUS (02206.HK): IPO closes with 1,115x margin orders, listing 11 Nov